Results 231 to 240 of about 396,275 (278)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Advanced gustometer design for reliable recording of gustatory event-related potentials in healthy young adults. [PDF]

Front Neurosci
Chen Z, Zhou X, Li C, Liu J.
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

High-Definition Transcranial Direct Current Stimulation Improves Pain Empathy: A Randomized, Double-Blind, and Sham-Controlled Study Based on Event-Related Potentials (ERPs). [PDF]

J Pain Res
Hu Z, Wen Y, Feng B, Wang Y, Lin Y, Shi J, Gong C, Wang Y.   +7 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Unconscious information processing of table tennis athletes in a masked priming paradigm: an event-related potentials (ERP) study. [PDF]

PeerJ
Meng F, Chen L, Xie C, Zheng J, Chen N, Qiu F, Geng J.   +6 more
europepmc   +1 more source

Decoding event-related potentials: single-dose energy dietary supplement acts on earlier brain processes than we thought. [PDF]

Front Neuroinform
Maciejewska KJ.
europepmc   +1 more source

Loneliness modulates the neural dynamics of language processing in healthy older adults: evidence from event-related potentials. [PDF]

Soc Cogn Affect Neurosci
Li B, Huang CM, Wang YY, Lin Q, Huang HW.   +4 more
europepmc   +1 more source

Decoding Analyses Show Dynamic Waxing and Waning of Event-Related Potentials in Coma Patients. [PDF]

Brain Sci
Herrera-Diaz A, Boshra R, Kolesar R, Pajankar N, Tavakoli P, Lin CY, Fox-Robichaud A, Connolly JF.   +7 more
europepmc   +1 more source

Effects of menstrual cycle phases on approach-avoidance behaviors in women: a behavioral and event-related potentials study. [PDF]

BMC Psychol
Li D, Xu C, Wang X.
europepmc   +1 more source